Tag Archive for: docetaxel
PSA Level at 6 Months as a Predictor of Long-Term Outcomes: Real 10-Year Overall Survival Data from the CHAARTED Trial
/0 Comments/in Post-hoc/by MaxRethinking Treatment for mHSPC: Insights from Dr. Karim Fizazi
/0 Comments/in Expert Insights, Observational, Retrospective studies/by MaxPhase 2 Adaptive ADT and Docetaxel Trial for mCSPC
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxInhibition of SREBP Reinduces Docetaxel Sensitivity in Advanced Prostate Cancer
/0 Comments/in Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial clinical trials crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STAMPEDE trial theranostics
Latest Posts
- LUNAR Trial Shows Combination Therapy Doubles Progression-Free Survival in Recurrent Prostate Cancer October 7, 2025
- ASPIRE Trial Explores Early Chemotherapy Addition for Advanced Prostate Cancer October 7, 2025
- Phase 1 Trial: 161Tb-PSMA Offers Hope After Lutetium Failure in mCRPC October 6, 2025
- Newsletter 40/2025 October 5, 2025